AI-enabled biotech startup analysis

We send weekly emails with analyses of biotech startups and scientific papers. You can find the analyses we've done thus far below (we started doing this in October 2023).

We use AI tools to write 95%+ of the text in these reports, with some light manual editing and a bit of human commentary here or there.

Startup analyses

This is not investment advice. AI does the research and writes the text. We proofread and fact-check each article, though we can't guarantee the analysis is 100% accurate. We are shooting for comprehensive yet concise first-pass review of companies.

Scientific paper analyses